3SAZ

3x Short AstraZeneca (AZN) ETP

3SAZ Product Description

GraniteShares 3x Short AstraZeneca Daily ETP is a collateralised, Exchange-Traded Product (ETP). The ETP tracks, excluding fees and other adjustments, the performance of the Solactive Daily Leveraged 3x Short AstraZeneca PLC Index that seeks to provide -3 times the daily performance of AstraZeneca PLC shares.

For example, if AstraZeneca PLC rises by 1% over a day, then the ETP will fall by 3%, excluding fees and other adjustments. However, if AstraZeneca PLC falls by 1% over a day, then the ETP will rise by 3%, excluding fees and other adjustments.

What is AstraZeneca(AZN)

AstraZeneca PLC is a biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. Its key areas include oncology, rare diseases, cardiovascular, renal and metabolic conditions, respiratory and immunology, and vaccines and immune therapies. The company develops and markets a range of treatments, including Tagrisso, Imfinzi, Lynparza, Calquence, Farxiga, Ultomiris, Soliris, Breztri, and others. AstraZeneca also engages in vaccine development and T-cell receptor therapies. It operates globally, serving healthcare providers and patients across the United Kingdom, the United States, Europe, and Asia. Founded in 1992 and headquartered in Cambridge, UK, AstraZeneca was formerly known as Zeneca Group PLC before adopting its current name in 1999.

Download
  Fact Sheet
  Prospectus
  KID

Key Facts

Tickers (Trading Currency)
3SAZ
ISIN
XS2703639117
Underlying Stock
Leverage Factor
-3x
Base Currency
GBP
Total Daily Ongoing Cost
0.0072%
Value per ETP Security as of 26 September 2023
£0.24107280
Dividend
Reinvested
Best ETP Provider

3x Short AstraZeneca (AZN) ETP OVERVIEW

LISTING AND CODES for 3x Short AstraZeneca (AZN) ETP

Exchange Trading
Currency
Ticker ISIN SEDOL WKN
London Stock Exchange GBX 3SAZ XS2703639117 BQ2JKV7

INDEX & PERFORMANCE of 3x Short AstraZeneca (AZN) ETP

1 Month 3 Months YTD 1 Year 3 Year Since Inception

COLLATERAL Details of 3x Short AstraZeneca (AZN) ETP

Understanding Collateral


Collateralised ETP Securities are backed with collateral, subject to eligibility criteria, to protect investors in event of default. The amount of collateral posted by the Swap Counterparty is held and valued by an independent custodian in a segregated account and is adjusted daily and reflects the collateralised ETPs' change in value and in the outstanding number of securities. The Bank of New York Mellon SA/NV serves as the Swap Collateral Custodian.

f